Moreover, the findings of our study showed higher concentrations of GPNMB in AD Aβ(+) patients in comparison to the Aβ(−) group, indicating a connection to amyloid pathology, which may be a result of the neuroprotective activity of GPNMB in the brain areas affected by amyloid plaques. The gene discussed is GPNMB; the disease is Alzheimer disease.